http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101285680-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-314 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L27-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23P10-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23P1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 |
| filingDate | 2011-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101285680-B1 |
| titleOfInvention | Beta-lactoglobulin / alginic acid nanoemulsion carrier containing bioactive substance using internal gelation technology and preparation method thereof |
| abstract | The present invention uses the internal gelation of beta lactoglobulin, alginic acid, and crosslinking agent calcium chloride, which is partially modified by heat treatment, to maximize the collection efficiency of coenzyme Q 10 , a bioactive substance, thereby preparing a bioavailable substance-containing nanoemulsion carrier with high bioavailability. It is. |
| priorityDate | 2011-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.